We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

120 hedge funds and large institutions have $580M invested in Collegium Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 48 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $319K

18% more capital invested

Capital invested by funds: $492M → $580M (+$88.3M)

0.9% more ownership

Funds ownership: 100.74% → 101.64% (+0.9%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 124 → 120 (-4)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

17% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 48

Holders
120
Holders Change
-4
Holders Change %
-3.23%
% of All Funds
2.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
40
Reduced
48
Closed
19
Calls
$1.2M
Puts
$319K
Net Calls
+$876K
Net Calls Change
-$4.3M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$20M
2
PA
Perceptive Advisors
New York
+$7.61M
3
RHJA
Rice Hall James & Associates
California
+$6.27M
4
UBS AM
UBS AM
Illinois
+$5.01M
5
Macquarie Group
Macquarie Group
Australia
+$3.79M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$14.2M
2
JGC
J. Goldman & Co
New York
-$8.81M
3
Morgan Stanley
Morgan Stanley
New York
-$8.16M
4
MC
Maverick Capital
Texas
-$6.22M
5
Two Sigma Investments
Two Sigma Investments
New York
-$3.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
EMG
126
Ellington Management Group
Connecticut
– -$411K -27,900 Closed
Man Group
127
Man Group
United Kingdom
– -$287K -19,445 Closed
Capital Fund Management (CFM)
128
Capital Fund Management (CFM)
France
– -$286K -19,400 Closed
JG
129
Jefferies Group
New York
– -$271K -18,405 Closed
IA
130
IFP Advisors
Florida
– -$195K -13,250 Closed
Manulife (Manufacturers Life Insurance)
131
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$163K -11,068 Closed
CSS
132
Cubist Systematic Strategies
Connecticut
– -$152K -10,309 Closed
STA
133
Summit Trail Advisors
New York
– -$102K -6,913 Closed
AIM
134
Assured Investment Management
New York
– -$75K -5,069 Closed
Group One Trading
135
Group One Trading
Illinois
– -$50.1K -2,926 Closed
PHK
136
Point72 Hong Kong
Hong Kong
– -$41K -2,798 Closed
TRCT
137
Tower Research Capital (TRC)
New York
– -$7K -447 Closed
Federated Hermes
138
Federated Hermes
Pennsylvania
– -$3K -190 Closed
IP
139
Intellectus Partners
California
– -$3K -171 Closed
2 3 4 5
6

COLL Hedge Fund Activity: Q4 2018 in Review

120 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2018, worth a combined $580M — up 18% from $492M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of COLL and 16 opened new positions — a net loss of 3 holders — while 48 trimmed existing stakes and 40 added.

The largest buyer was Millennium Management, adding an estimated $20M. The largest seller was Sectoral Asset Management, cutting an estimated $14.2M.

  • 120 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2018, down from 124 in Q3 2018.
  • Funds reported $580M of Collegium Pharmaceutical stock for Q4 2018, up 18% quarter-over-quarter.
  • 16 funds opened new Collegium Pharmaceutical positions in Q4 2018 and 19 closed out, a net change of -3 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2018 was Millennium Management, an estimated $20M added.
  • The largest Collegium Pharmaceutical seller in Q4 2018 was Sectoral Asset Management, an estimated $14.2M sold.

Based on aggregated 13F filings for Q4 2018.